Founder, Nurix and Lyterian Therapeutics
Excited about stress responses, ubiquitin, proteasome, targeted protein degradation, drug discovery
@mti-ucb.bsky.social member @olzmannlab.bsky.social for receiving the Beatriz Manz award for 'transformational teaching and community service'. Glad to have you as a friend and colleague @ucberkeleyofficial.bsky.social, James!
@mti-ucb.bsky.social member @olzmannlab.bsky.social for receiving the Beatriz Manz award for 'transformational teaching and community service'. Glad to have you as a friend and colleague @ucberkeleyofficial.bsky.social, James!
@jenniferdoudna.bsky.social @ucberkeleyofficial.bsky.social
@jenniferdoudna.bsky.social @ucberkeleyofficial.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
@ucberkeleyofficial.bsky.social and giving an inspiring fireside chat. It's such a privilege to learn from innovators in drug discovery who consistently push the boundaries of what's possible.
@ucberkeleyofficial.bsky.social and giving an inspiring fireside chat. It's such a privilege to learn from innovators in drug discovery who consistently push the boundaries of what's possible.